ESCAPE THERAPEUTICS INC has a total of 30 patent applications. Its first patent ever was published in 2008. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are HANTASH BASIL M, AGEX THERAPEUTICS INC and TOKYO METROPOLITAN INST MEDICAL SCIENCE.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 14 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | China | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Republic of Korea | 2 | |
#6 | Australia | 1 | |
#7 | Brazil | 1 | |
#8 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Measurement | |
#5 | Medical technology | |
#6 | Agriculture |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Specific use of cosmetics | |
#6 | Analysing materials | |
#7 | Animal care | |
#8 | Object sterilising | |
#9 | Diagnosis and surgery | |
#10 | Electrotherapy |
# | Name | Total Patents |
---|---|---|
#1 | Hantash Basil M | 27 |
#2 | Ubeid Anan Abu | 8 |
#3 | Wang Ying | 2 |
#4 | Hantash Basil | 2 |
#5 | Ubeid Anan | 1 |
#6 | Basil M Hantash | 1 |
#7 | Anan Abu Ubeid | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020150718A1 | Tyrosine inhibitors with immunosuppressive activity in human neonatal keratinocyte progenitors | |
CN110770248A | Decapeptide-12 regulation of deacetylase gene expression in epidermal keratinocyte progenitor cells | |
US2017065639A1 | Mesenchymal stem cells with enhanced immunosuppressive capability | |
US2015152139A1 | Peptide tyrosinase activators | |
US9554746B1 | System for evaluating skin treatment | |
WO2014113704A2 | Enhanced differentiation of mesenchymal stem cells | |
WO2011116072A1 | Hybrid hydrogel scaffold compositions and methods of use |